$1.86
0.00% (Daily)
Market Cap
$4.22M
Revenue
$N/A
Rank by MCap
#1974
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Ryan M. Confer M.S.
Headquarters
Austin, TX
Employees
13
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Re...
Loading chart…